AstraZeneca have announced that they have stopped their policy of paying for doctors to attend international medical conferences. As healthcare costs have risen, there has been an increased concern about the financial ties between drug makers and doctors.

The company’s latest decision is so far believed to be unprecedented in the industry and is seen as a reaction to the Bribery Act that is coming into force in the UK on 1 July.